Appili Therapeutics Stock Target Price
| APLI Stock | CAD 0.02 0.01 20.00% |
As of the 20th of February, Appili Therapeutics shows the Risk Adjusted Performance of 0.0416, downside deviation of 20.57, and Mean Deviation of 8.73. Appili Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Appili Therapeutics Total Revenue |
|
Gross Profit | Market Capitalization | Enterprise Value Revenue 71.6082 | Revenue | Earnings Share (0.02) |
Appili | Target Price |
Appili Target Price Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Appili Therapeutics' direct or indirect competition against its Target Price to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Appili Therapeutics could also be used in its relative valuation, which is a method of valuing Appili Therapeutics by comparing valuation metrics of similar companies.Appili Therapeutics is currently under evaluation in target price category among its peers.
Appili Therapeutics Current Valuation Drivers
We derive many important indicators used in calculating different scores of Appili Therapeutics from analyzing Appili Therapeutics' financial statements. These drivers represent accounts that assess Appili Therapeutics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Appili Therapeutics' important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 65.7M | 8.0M | 4.5M | 4.2M | 4.9M | 4.6M | |
| Enterprise Value | 6.3M | 9.7M | 12.3M | 15.3M | 17.6M | 21.8M |
Appili Fundamentals
| Return On Equity | -9.39 | ||||
| Return On Asset | -2.69 | ||||
| Operating Margin | (88.64) % | ||||
| Current Valuation | 14.3 M | ||||
| Shares Outstanding | 121.27 M | ||||
| Shares Owned By Insiders | 0.06 % | ||||
| Shares Owned By Institutions | 11.84 % | ||||
| Number Of Shares Shorted | 5.98 K | ||||
| Price To Book | 1.40 X | ||||
| Price To Sales | 11.76 X | ||||
| Revenue | 100.44 K | ||||
| Gross Profit | 100.44 K | ||||
| EBITDA | 360.57 K | ||||
| Net Income | (2.62 M) | ||||
| Cash And Equivalents | 5.55 M | ||||
| Cash Per Share | 0.05 X | ||||
| Total Debt | 12.29 M | ||||
| Current Ratio | 1.99 X | ||||
| Book Value Per Share | (0.12) X | ||||
| Cash Flow From Operations | 868.82 K | ||||
| Short Ratio | 0.01 X | ||||
| Earnings Per Share | (0.02) X | ||||
| Target Price | 0.15 | ||||
| Beta | 0.13 | ||||
| Market Capitalization | 3.03 M | ||||
| Total Asset | 3.03 M | ||||
| Retained Earnings | (71.72 M) | ||||
| Working Capital | (12.68 M) | ||||
| Net Asset | 3.03 M |
About Appili Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Appili Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Appili Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Appili Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Appili Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Appili Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Appili Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Appili Stock
| 0.39 | BCE | BCE Inc | PairCorr |
| 0.39 | AIM | Aimia Inc | PairCorr |
| 0.39 | RKR | ROKMASTER Resources Corp | PairCorr |
| 0.39 | CU-PH | Canadian Utilities Earnings Call This Week | PairCorr |
| 0.37 | ETG | Entree Resources | PairCorr |
The ability to find closely correlated positions to Appili Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Appili Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Appili Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Appili Therapeutics to buy it.
The correlation of Appili Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Appili Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Appili Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Appili Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Appili Stock
Appili Therapeutics financial ratios help investors to determine whether Appili Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Appili with respect to the benefits of owning Appili Therapeutics security.